The 83rd AOA Scientific meeting I believe is about to be held, this is a great opportunity to bring awareness to the wider medical community in Australia. Also great to see we have ditched J & J and will be pursuing other pathways to the American market J & J has been a ball and chain.
Pretty obvious for all patients needing treatment - would you go invasive surgery or ATI.
Undoubtably this treatment path will be first in class.
Ann: Successful OrthoATI clinical trial, page-11
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $75.35M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 36.5¢ | 36.0¢ | $38.33K | 106.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 50369 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 11840 | 5 |
View Market Depth
| Last trade - 12.04pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
35.5¢ |
Change
-0.005 ( 2.74 %) |
||||
| Open | High | Low | Volume | ||
| 36.0¢ | 36.0¢ | 35.5¢ | 86639 | ||
| Last updated 15.54pm 05/06/2024 ? | |||||
| OCC (ASX) Chart |